• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493941824400
Medical Device Problem Codes Break (1069); Failure to Advance (2524)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/28/2022
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The target lesion was located in the highly calcified right coronary artery.A 4.00 x 24mm synergy xd drug-eluting stent was advanced for treatment, however, during procedure while trying to cross the lesion the shaft break.The procedure was completed with another of the same device.There were no complications reported and the patient is stable.
 
Event or Problem Description
It was reported that shaft break occurred.The target lesion was located in the highly calcified right coronary artery.A 4.00 x 24mm synergy xd drug-eluting stent was advanced for treatment, however, during procedure while trying to cross the lesion the shaft break.The procedure was completed with another of the same device.There were no complications reported and the patient is stable.
 
Additional Manufacturer Narrative
Updated b5: describe event or problem.
 
Event or Problem Description
It was reported that shaft break occurred.The target lesion was located in the highly calcified right coronary artery.A 4.00 x 24mm synergy xd drug-eluting stent was advanced for treatment, however, during procedure while trying to cross the lesion the shaft break.The procedure was completed with another of the same device.There were no complications reported and the patient is stable.It was further that the lesion was severely calcified and moderately tortuous.A resistance was felt while advancing and the shaft break halfway.The device was completely removed from the patient's body by pulling out with hands.
 
Event or Problem Description
It was reported that shaft break occurred.The target lesion was located in the highly calcified right coronary artery.A 4.00 x 24mm synergy xd drug-eluting stent was advanced for treatment, however, during procedure while trying to cross the lesion the shaft break.The procedure was completed with another of the same device.There were no complications reported and the patient is stable.It was further that the lesion was severely calcified and moderately tortuous.A resistance was felt while advancing and the shaft break halfway.The device was completely removed from the patient's body by pulling out with hands.
 
Additional Manufacturer Narrative
A synergy xd mr us 4.00 x 24mm stent delivery system was returned for analysis.A visual examination of the stent found no issues.There was no sign of damage, stretching or lifting of the stent struts.The stent showed no signs of movement and was set between the proximal and distal markerbands.The stent od (outer diameter) was measured using snap gauge and the result was within max crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip showed no signs of distal tip damage.A visual and tactile examination of the hypotube shaft found multiple kinks and a break 23.8 cm distal to the strain relief.A visual and tactile examination of the outer and mid-shaft section and a visual examination of the inner lumen found no issues along the shaft polymer extrusion.No other issues were identified during analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13530274
Report Number2134265-2022-01575
Device Sequence Number14739498
Product Code NIQ
UDI-Device Identifier08714729981145
UDI-Public08714729981145
Combination Product (Y/N)Y
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/15/2023
Device Model NumberH7493941824400
Device Lot Number0027748412
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/21/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/28/2022
Supplement Date Received by Manufacturer02/02/2022
02/24/2022
Initial Report FDA Received Date02/14/2022
Supplement Report FDA Received Date02/17/2022
03/09/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/15/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age71 YR
Patient SexUnknown
-
-